Projects per year
Abstract
Adenosine receptors are attractive therapeutic targets for multiple conditions, including ischemia-reperfusion injury and neuropathic pain. Adenosine receptor drug discovery efforts would be facilitated by the development of appropriate tools to assist in target validation and direct receptor visualization in different native environments. We report the development of the first bifunctional (chemoreactive and clickable) ligands for the adenosine A1 receptor (A1R) and adenosine A3 receptor (A3R) based on an orthosteric antagonist xanthine-based scaffold and on an existing structure-activity relationship. Bifunctional ligands were functional antagonists with nanomolar affinity and irreversible binding at the A1R and A3R. In-depth pharmacological profiling of these bifunctional ligands showed moderate selectivity over A2A and A2B adenosine receptors. Once bound to the receptor, ligands were successfully "clicked"with a cyanine-5 fluorophore containing the complementary "click"partner, enabling receptor detection. These bifunctional ligands are expected to aid in the understanding of A1R and A3R localization and trafficking in native cells and living systems.
Original language | English |
---|---|
Pages (from-to) | 8161–8178 |
Number of pages | 18 |
Journal | Journal of Medicinal Chemistry |
Volume | 64 |
Issue number | 12 |
DOIs | |
Publication status | Published - 14 Jun 2021 |
Projects
- 5 Finished
-
Adenosine A1 receptor modulation: Structure, dynamics & novel pharmacological interventions
Christopoulos, A., May, L., Imlach, W., Hill, S. & Scott, D.
1/01/18 → 31/12/22
Project: Research
-
Adenosine Receptor Context-Specific Biased Agonism to Treat Ischaemic Heart Disease
May, L., White, P. & Kompa, A.
1/01/18 → 31/12/20
Project: Research
-
Exploring metabotropic glutamate receptor 5 bias, allostery and heteromers
1/07/17 → 30/12/21
Project: Research